affiliation not provided to SSRN
Enhanced Recovery After Surgery, pelvic exenteration, gynecologic surgery, surgical outcomes
Recurrent ovarian cancer, High-grade serous ovarian cancer (HGSOC), Platinum resistant ovarian cancer (PROC), Cyclophosphamide, Bevacizumab.
Endometrial Stromal Sarcoma, low-grade ESS, uterine sarcoma, hormonal therapy, Megace, Letrozole
clear cell carcinoma, cervical carcinoma, vaginal carcinoma, post-DES era, cCCC, vCCC
ovarian cancer, fallopian tube cancer, bevacizumab, angiogenesis inhibitors